شرکت گروه دارویی برکت
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
بدون نتیجه
مشاهده تمام نتایج
شرکت گروه دارویی برکت
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
  • Media
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
صفحه اصلی Stock News

The organization of the stock exchange and securities was examined

“Barakat” received a license to increase its capital by 27%

bpharmed توسط bpharmed
20 فروردین 1401
در Stock News
0 0
A A
0
0
اشتراک گذاری ها
835
بازدیدها

According to the Young Reporters Club Economic Group Stock Exchange Reporter, based on an advertisement published on the Kadal website (Exchange Publishers Information System) by Barakat Pharmaceutical Group Company on September 1, 1400, Barakat shares were allowed to increase their capital by 27% from shareholders’ current claims and brought cash. In the amount of 154 billion Tomans, it was issued as follows:

Pursuant to the Securities Market Law of the Islamic Republic of Iran (approved in December 2005), the demand for capital increase and the issuance of new shares of Barakat Public Joint Stock Company) in the Stock Exchange and Securities Organization were examined.

پست قبلی

Take a look at the portfolio of Barakat Pharmaceutical Group in January

پست‌ بعدی

Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus

bpharmed

bpharmed

پست‌ بعدی
Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus

Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus

دیدگاهتان را بنویسید لغو پاسخ

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

The specific vaccine “omicron” is produced by Iranian scientists

The result of a scientific study on the effectiveness of the Barakat vaccine

“Barakat” received a license to increase its capital by 27%

Take a look at the portfolio of Barakat Pharmaceutical Group in January

Shareholders read “Barakat” (January 7) / Price drop for the third day in a row

Barkat Pharmaceutical Group is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company’s name was was changed to “Tadbir innovation pharmaceutical company” in 2010.

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

14 آذر 1401
The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

14 خرداد 1401

Contact Us

Address : No. 11, 5th Alley, Bucharest Ave, Argentina Sq, Tehran, Iran

Phone :  +98 21 88480161

Email : info@bpharmed.com

Email Affairs Stock : stock@bpharmed.com

Follow Us

Copyright © 2020-2025 by www.bpharmed.com All Rights Reserved
powered by ravian

  • Subsidiaries
  • About Us
  • Contact Us
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian

Copyright © 2020-2025 by www.bpharmed.com All Rights Reserved
powered by ravian

خوش آمدید!

به حساب خود در زیر وارد شوید

رمز عبور را فراموش کرده اید؟

رمز عبور خود را بازیابی کنید

لطفا نام کاربری یا آدرس ایمیل خود را برای بازنشانی رمز عبور خود وارد کنید.

ورود به سیستم

Add New Playlist